Rating
Hold
Price target
$42
Previous
$35
Implied downside
-23%

Stifel analyst Ruben Roy raised the price target on Intel (NASDAQ: INTC) to $42.00 (from $35.00) while maintaining a Hold rating.

“INTC delivered a robust 4Q beat ($13.7bn revenue, 37.9% adj-GM, $0.15 adj-EPS vs. $13.4bn, 36.5%, $0.08) on strong DCAI performance, but Q1 guidance disappointed ($12.2bn, 34.5%, $0.00 vs. $12.6bn, 36.1%, $0.06) as “hand-to-mouth” inventory (40% of peak) created a temporary supply bottleneck amid high demand for server CPUs (positive implications for AMD) and just-ramping 18A production.

Utilization is near capacity, however efficiency in terms of yields, consistency, mix, and pricing offer levers of organic improvement without growing CapEx.

1Q should be the fundamental trough; margins should rebound toward 40% by 1H27 as 18A yields improve at a +7-8% monthly cadence toward industry standards.

We view 2H26-1H27 as a potential catalyst window, in which INTC will host their first Investor Day under LBT, and could denote an infection point for firm long-term 14A volume commitments and advanced packaging ramps.

For now, though, shares appear fairly valued to us. TP to $42.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.